EN DE

Gentech Holdings Inc (GTEH) Fair Value & Analysis

Consumer Cyclical · US · Market cap $610

GH Gentech Holdings Inc logo Gentech Holdings Inc GTEH · US
Price$0.0001
Fair Value$0.0001
Upside+0.0%
Quality29/100
Watch Gentech Holdings Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 0.0% net margin
Low debt · negative free cash flow
Trails peers (2/8)
Narrow moat 12/100
Evidence: Low Range $0.0001 – $0.0001 Share as image

Fair value as of: Aug 13, 2026

From 1 valuation models · updated 4 days ago

Fair value updated Aug 13, 2026, revised from $0.0005 to $0.0001 (−79.9%) since Jul 29, 2026.

Below-average quality, currently priced close to our fair value.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$3.50 $0.0000 Fair Value $0.0001 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $0.0000 – $3.50 · the $0.0001 price screens below the $0.0001 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Gentech Holdings Inc (GTEH) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 29/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

For context, the median of 10 Consumer Cyclical peers we cover trades at -51% fair-value upside, at 0%, GTEH screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) $0.0001 $0.0001 $0.0001 50
All 1 models by family
Asset-Based
NCAV (Graham) $0.0001 $0.0001 $0.0001 50

Notify me when GTEH reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Free cash flow −$7.9M FY2021
EPS (TTM) $-12.68
Net debt $888K FY2021

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 29/100

Of which business quality 33 · Market factors (momentum, volatility) 44

Profitability 0
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 40
Earnings quality: real cash, not paper profit
Fin. Strength 69
Balance sheet, leverage, solvency risk
Investment 50
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 67
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

GenTech Holdings, Inc. operates a chain of hemp centric coffee shop retail spaces under the Healthy Leaf brand name. The company offers CBD-infused chocolates, skin creams, artisan teas, artisan coffee, wellness snack bars, and pet treats through its retail spaces. It also provides holistic education and classes.

Full company description

GenTech Holdings, Inc. operates a chain of hemp centric coffee shop retail spaces under the Healthy Leaf brand name. The company offers CBD-infused chocolates, skin creams, artisan teas, artisan coffee, wellness snack bars, and pet treats through its retail spaces. It also provides holistic education and classes. The company was founded in 2013 and is based in New York, New York.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2016 – FY2021 · reported fiscal years

Gentech Holdings Inc reported revenue of $909K in FY2021 versus $203K in FY2016, a compound +34.9%/yr. Reported net income was −$4.3M in FY2021.

Growth Quality 36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2021)
$909K
Latest YoY
+259.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+64.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+34.9%
Avg. growth/yr (8Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+233.1%
Revenue +34.9%/yr
FY16 $203K
FY17 $106
FY18 $203K
FY20 $253K
FY21 $909K
Net income
FY17 −$406K
FY18 −$222K
FY19 −$784K
FY20 −$1.1M
FY21 −$4.3M

Watch GTEH: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Gentech Holdings Inc Fair Value". https://www.fairvalue-calculator.com/stock/GTEH

Peer Group

Restaurants · 228 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 33 · Bottom 25%
Fair Value upside +0% · Above median
Return on assets 0% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) 0% · Below median
Revenue growth 0% · Below median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 33 · sector 20
FUTURE 0 · sector 19
PAST 0 · sector 14
HEALTH 100 · sector 97
DIVIDEND 0 · sector 71

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Restaurants stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
McDonald's Corporation MCDS C$24.01 C$10.84 -55%
Starbucks Corporation SBUX $108.49 $35.83 -67%
Chipotle Mexican Grill, Inc CMG $32.00 $17.92 -44%
Yum! Brands, Inc YUM $150.34 $58.17 -61%
Restaurant Brands International Inc QSR C$104.50 C$36.37 -65%
Darden Restaurants, Inc DRI $218.90 $173.68 -21%
Yum China Holdings YUMC $47.90 $54.27 +13%
Texas Roadhouse, Inc TXRH $214.28 $104.89 -51%
Dutch Bros Inc BROS $51.02 $12.80 -75%
Domino's Pizza, Inc DPZ $353.72 $227.31 -36%

Compare Gentech Holdings Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Gentech Holdings Inc (GTEH) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001, about +0% (fairly valued).
What is the fair value of GTEH?
Our model-based fair value for Gentech Holdings Inc is $0.0001 (as of Aug 13, 2026), built from audited fundamentals. The current price is $0.0001.
What is the quality score of GTEH?
Gentech Holdings Inc has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the net profit margin of GTEH?
The net profit margin of Gentech Holdings Inc is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Gentech Holdings Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.